Pre-anesthetics or muscle relaxants are drugs that act on the Central Nervous System (CNS).
Anait S. Levenson, M.D., Ph.D, is a lecturer on drugs acting on the Central Nervous System (CNS).
The lecture on pre-anesthetics or muscle relaxants was held on October 9, 2023.
The office hours for Anait S. Levenson, M.D., Ph.D, are by appointment, which can be arranged by sending an email to anait.levenson@liu.edu.
An adjunct or pre-anesthetic is a drug that is not a true anesthetic, but that is used during anesthesia to produce other desired effects such as sedation, muscle relaxation, analgesia, reversal, neuromuscular blockade, or parasympathetic blockade.
Pre-anesthetics or muscle relaxants are used prior to the administration of an anesthetic agent to make anesthesia safe and more agreeable to the patient.
Baclofen, another type of centrally acting muscle relaxant, has less sedation than diazepam.
Centrally acting muscle relaxants include spasmolytics such as benzodiazepines, GABA agonists, and α2 agonists.
Guaifenesin has minimal respiratory effects and adverse effects include allergic reaction in horses and overdose can cause bradycardia, hypotension, extensor rigidity, apnea, and cardiac arrest.
Mathocarbamol, a Guaifenesin analog, is used to treat muscle spasms in dogs and cats.
Guaifenesin (5%) solution is combined with additional α2 agonist and ketamine to create so called “Triple Drip”, which prolongs anesthesia up to an hour.
Guaifenesin causes mild sedation and analgesia, and decreases blood pressure in horses, but minimal effect on heart rate.
Peripheral acting muscle relaxants have sedative and musculoskeletal relaxant properties.
Baclofen has a narrow margin of safety, clinical use is infrequent, causes loss of the gag reflex putting dogs at high risk for aspiration, and can cause severe vomiting, seizures and cardiac arrest.
Diazepam, a type of centrally acting muscle relaxant, has significant sedation but milder than that produced by other sedative-hypnotic drugs at doses that induce equivalent muscle relaxation.
Centrally acting muscle relaxants have sedative and musculoskeletal relaxant properties.
Tizanidine, a type of centrally acting muscle relaxant, causes asthenia, drowsiness, dry mouth, and hypotension.
Baclofen, a centrally acting muscle relaxant, is used to treat urinary retention by reducing urethral resistance and gastroesophageal reflux.
Baclofen mimics GABA (agonist, GABA B ) within the spinal cord and works by depressing afferent reflex activity at the spinal cord level, thereby reducing skeletal muscle spasm.
Neuromuscular Blocking Agents (NMBAs) are a type of centrally acting muscle relaxant.
Guaifenesin, a centrally acting spasmolytic, is used in IV combination with thiobarbiturates and ketamine for induction of anesthesia in horses, cattle, and swine.
Neuromuscular Blocking Agents (NMBAs) are a type of peripheral acting muscle relaxant.
Centrally acting muscle relaxants have a site of spasmolytic action in the spinal cord.
Adverse effects of Baclofen include dizziness, drowsiness, and ataxia.
Increase heart rate ( prevent bradycardia )
Pre-anesthetic medications include combinations of drugs from multiple categories such as opioids, tranquilizers, muscle relaxants, and anticholinergics.
Aim of spasmolytics : reduction of excessive skeletal muscle tone without reduction of muscle strength
Reversal of: α2 - Antagonists
Prevent, limit saliva tion and respiratory secretions and emesis and limit or prevent bradycardia